Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8

J Labadie; E.D. de Kleijn; AB Lafeber; MMM Mees; K Booy; R. de Groot; G-W van Omme; H. van Dijken; AJ Kuipers; G van den Dobbelsteen; R.E. Juttmann; M Wala; A.J.W. van Alphen; HC Rümke

Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8

J Labadie, E.D. de Kleijn, AB Lafeber, MMM Mees, K Booy, R. de Groot, G-W van Omme, H. van Dijken, AJ Kuipers, G van den Dobbelsteen, R.E. Juttmann, M Wala, A.J.W. van Alphen, HC Rümke

Research output: Book/Report/Inaugural speech/Farewell speech › Report › Professional

Original language	English
Place of Publication	Bilthoven
Commissioning body	Chief Inspectorate of Health Care (IGZ)
Number of pages	69
Publication status	Published - Nov 2000

Publication series

Series	RIVM Report
Number	124001 004

Research programs

EMC MM-04-54-08-A

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

124001004Final published version, 430 KB

https://www.rivm.nl/bibliotheek/rapporten/124001004.html

Cite this

Labadie, J., de Kleijn, E. D., Lafeber, AB., Mees, MMM., Booy, K., de Groot, R., van Omme, G.-W., van Dijken, H., Kuipers, AJ., van den Dobbelsteen, G., Juttmann, R. E., Wala, M., van Alphen, A. J. W., & Rümke, HC. (2000). Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8. RIVM Report No. 124001 004 https://www.rivm.nl/bibliotheek/rapporten/124001004.html

@book{efaf158782fa451393b6ac73ba9071cd,

title = "Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8",

author = "J Labadie and {de Kleijn}, E.D. and AB Lafeber and MMM Mees and K Booy and {de Groot}, R. and {van Omme}, G-W and {van Dijken}, H. and AJ Kuipers and {van den Dobbelsteen}, G and R.E. Juttmann and M Wala and {van Alphen}, A.J.W. and HC R{\"u}mke",

year = "2000",

month = nov,

language = "English",

series = "RIVM Report",

number = "124001 004",

}

Labadie, J, de Kleijn, ED, Lafeber, AB, Mees, MMM, Booy, K, de Groot, R, van Omme, G-W, van Dijken, H, Kuipers, AJ, van den Dobbelsteen, G, Juttmann, RE, Wala, M, van Alphen, AJW & Rümke, HC 2000, Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8. RIVM Report, no. 124001 004, Bilthoven. <https://www.rivm.nl/bibliotheek/rapporten/124001004.html>

TY - BOOK

T1 - Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8

AU - Labadie, J

AU - de Kleijn, E.D.

AU - Lafeber, AB

AU - Mees, MMM

AU - Booy, K

AU - de Groot, R.

AU - van Omme, G-W

AU - van Dijken, H.

AU - Kuipers, AJ

AU - van den Dobbelsteen, G

AU - Juttmann, R.E.

AU - Wala, M

AU - van Alphen, A.J.W.

AU - Rümke, HC

PY - 2000/11

Y1 - 2000/11

M3 - Report

T3 - RIVM Report

BT - Safety and immunogenicity of the RIVM hexavalent meningococcal B vesicle vaccine for Rotterdam children aged 2-3 and 7-8

CY - Bilthoven

ER -